Featured Research

from universities, journals, and other organizations

Injectable Gel Effective In Treating Head And Neck Cancer

Date:
August 16, 2002
Source:
Journal Of The American Medical Association
Summary:
An injectable gel combining cisplatin, a chemotherapy drug, and epinephrine is effective in treating cancers of the head and neck, according to a new study published in The Archives of Otolaryngology and Head and Neck Surgery, one of the JAMA/Archives journals.

CHICAGO – An injectable gel combining cisplatin, a chemotherapy drug, and epinephrine is effective in treating cancers of the head and neck, according to a new study published in The Archives of Otolaryngology and Head and Neck Surgery, one of the JAMA/Archives journals.

Squamous cell carcinoma is a type of cancer that originates in a particular type of cell found in many different parts of the body. Head and neck squamous cell carcinoma (HNSCC) refers to this type of cancer in the head or neck.

According to background information, HNSCC is diagnosed in about 40,000 Americans each year and more than 600,000 people worldwide. Barry L. Wenig, M.D., M.P.H., of Northwestern Medical School, Evanston, Ill., and colleagues investigated the use of cisplatin/epinephrine gel injected directly into the tumor in patients with HNSCC. Cisplatin given intravenously (by vein) has been shown to be a potent agent for treating HNSCC, but because it affects the entire body when given intravenously, it can have serious adverse effects.

The authors write "Therapeutic options for advanced HNSCC are limited. These patients generally have undergone extensive surgery, have received near-maximum tolerated doses of radiation, and are often poor candidates for aggressive combination therapy. Therefore, for more effective local and regional control of HNSCC and to minimize systemic exposure and toxicity, locally injectable therapies have been investigated."

The researchers conducted two placebo-controlled phase III trials of identical design. One hundred seventy patients previously treated for their cancers were enrolled (one patient was later excluded). Eighty- nine percent of the patients were treated with more than one treatment including surgery, chemotherapy and radiotherapy. One hundred nineteen patients received the cisplatin/epinephrine gel, and 59 patients received a placebo gel. Patients' tumors were injected up to 6 times per week over 8 weeks with weekly evaluations for four weeks after treatment and monthly evaluations thereafter. Patients with nonresponsive tumors after three weeks of treatment could switch from placebo group to treatment group.

Tumors responded in 35 of 119 patients receiving the cisplatin/epinephrine gel (29 percent). Twenty-three (19 percent) had complete responses with the cisplatin/epinephrine gel vs. 2 percent for those in the placebo gel groups (1 in 59 patients). Patients in the treatment group also met more of their treatment goals (27 percent vs. 12 percent in the placebo group). Treatment goals included improved pain control, improved wound care, relief of symptoms and better physical appearance.

"In these two randomized, double-blind, placebo-controlled phase II trials, cisplatin/epinephrine gel was shown to be effective in producing clinically meaningful response and palliative benefit in a group of patients with advanced HNSCC who had few, if any, remaining therapeutic options. Moreover, the strong association between response and patient benefit clearly demonstrated the advantage of treatment over placebo," the authors write.

Editor's Note: This study was supported by a clinical grant from Matrix Pharmaceutical Inc., Fremont, Calif.


Story Source:

The above story is based on materials provided by Journal Of The American Medical Association. Note: Materials may be edited for content and length.


Cite This Page:

Journal Of The American Medical Association. "Injectable Gel Effective In Treating Head And Neck Cancer." ScienceDaily. ScienceDaily, 16 August 2002. <www.sciencedaily.com/releases/2002/08/020815073239.htm>.
Journal Of The American Medical Association. (2002, August 16). Injectable Gel Effective In Treating Head And Neck Cancer. ScienceDaily. Retrieved October 20, 2014 from www.sciencedaily.com/releases/2002/08/020815073239.htm
Journal Of The American Medical Association. "Injectable Gel Effective In Treating Head And Neck Cancer." ScienceDaily. www.sciencedaily.com/releases/2002/08/020815073239.htm (accessed October 20, 2014).

Share This



More Health & Medicine News

Monday, October 20, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Microneedle Patch Promises Painless Pricks

Microneedle Patch Promises Painless Pricks

Reuters - Innovations Video Online (Oct. 18, 2014) Researchers at The National University of Singapore have invented a new microneedle patch that could offer a faster and less painful delivery of drugs such as insulin and painkillers. Video provided by Reuters
Powered by NewsLook.com
Raw: Nurse Nina Pham Arrives in Maryland

Raw: Nurse Nina Pham Arrives in Maryland

AP (Oct. 17, 2014) The first nurse to be diagnosed with Ebola at a Dallas hospital walked down the stairs of an executive jet into an ambulance at an airport in Frederick, Maryland, on Thursday. Pham will be treated at the National Institutes of Health. (Oct. 16) Video provided by AP
Powered by NewsLook.com
Raw: Cruise Ship Returns to US Over Ebola Fears

Raw: Cruise Ship Returns to US Over Ebola Fears

AP (Oct. 17, 2014) A Caribbean cruise ship carrying a Dallas health care worker who is being monitored for signs of the Ebola virus is heading back to Texas, US, after being refused permission to dock in Cozumel, Mexico. (Oct. 17) Video provided by AP
Powered by NewsLook.com
Spanish Govt: Four Suspected Ebola Cases in Spain Test Negative

Spanish Govt: Four Suspected Ebola Cases in Spain Test Negative

AFP (Oct. 17, 2014) All four suspected Ebola cases admitted to hospitals in Spain on Thursday have tested negative for the deadly virus in a first round of tests, the government said Friday. Duration: 00:55 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins